eye treatment biosimilar

SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

HD Hyundai Heavy Industries Co., the world’s largest shipbuilder, is seeking to launch maintenance, repair and overhaul (MRO) services for the...

A new year has arrived, and with it come the New Year’s resolutions. However, if you are one of those who feel you've already failed to keep y...

Hyundai Motor Co. and its sibling Kia Corp. have set a target to sell a combined 7.39 million units around the globe this year with greater focus on...

South Korea’s largest shipbuilder, HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE), said Friday it aims to win $180.05 billion ...

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

K Bank, a South Korean online lender, is making a fresh attempt to list on the Korean stock market in February 2025 as bitcoin’s record-breaki...

South Korea’s top automaker Hyundai Motor Co. will likely entrust the manufacturing of its automotive chips for self-driving vehicles to Samsu...

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...

SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

HJ Shipbuilding & Construction Co. (HJ S&C) said on Wednesday it won a 124.7 billion won ($894 million) contract from the Defense Acquisit...

South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (...

Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...

Bering Lab Inc., a South Korea-based artificial intelligence technology-powered translation startup with specialties in legal, financial and intelle...

South Korea's Samsung Bioepis Co., Samsung Biologics Co.'s fully owned biosimilar subsidiary, and the US-based Biogen said on Tuesday the European C...

HYBE Co., the K-pop behemoth behind BTS, suffered a double-digit profit fall in the third quarter amid an ongoing feud with Min Hee-jin, the creativ...

South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...

South Korea’s leading rice cooker and small appliance maker Cuckoo Holdings Co. is said to be seeking to list its Malaysian unit in the Southe...

South Korea's DS Dansuk Co., which operates bioenergy, battery, and plastic recycling businesses, said on Monday it signed a 1 trillion won ($750 mi...

TheBorn Korea Inc., a leading South Korean food and beverage group operated by TV celebrity and chef Paik Jong-won, is looking to acquire soy sauce ...

South Korea's Samsung Display said on Monday it developed technology to recycle quantum dot (QD) ink, aiming to improve cost competitiveness in its ...

Kia Corp., South Korea’s No. 2 carmaker after Hyundai Motor Co., presented a brighter outlook for this year after posting record-high operatin...

ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...

Samsung Bioepis Co., Samsung Biologics Co.'s fully owned biosimilar subsidiary, is expected to post its best-ever annual revenue this year after sal...

POSCO International Corp., the general trading and energy exploration unit of South Korea’s steel giant POSCO Holdings Inc., is considering ac...

South Korea's major pension and savings funds see no drastic reshuffle to their portfolios tilted to private debts next year. But they are looking t...